LifeVantage Stock Forecast, Price & News

+0.02 (+0.25 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume49,784 shs
Average Volume118,605 shs
Market Capitalization$113.72 million
P/E Ratio10.02
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive LFVN News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LifeVantage logo

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The company offers Protandim, a line of scientifically-validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, and hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. The company sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and China. LifeVantage Corporation is headquartered in Sandy, Utah.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.28 out of 5 stars

Medical Sector

1141st out of 2,216 stocks

Pharmaceutical Preparations Industry

536th out of 869 stocks

Analyst Opinion: 0.0Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

LifeVantage (NASDAQ:LFVN) Frequently Asked Questions

What stocks does MarketBeat like better than LifeVantage?

Wall Street analysts have given LifeVantage a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LifeVantage wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting LifeVantage?

LifeVantage saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 293,200 shares, a drop of 50.3% from the June 15th total of 590,200 shares. Based on an average trading volume of 129,400 shares, the short-interest ratio is presently 2.3 days. Approximately 2.3% of the shares of the stock are short sold.
View LifeVantage's Short Interest

When is LifeVantage's next earnings date?

LifeVantage is scheduled to release its next quarterly earnings announcement on Tuesday, August 17th 2021.
View our earnings forecast for LifeVantage

How were LifeVantage's earnings last quarter?

LifeVantage Co. (NASDAQ:LFVN) announced its quarterly earnings results on Monday, February, 1st. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.03. The firm earned $59.01 million during the quarter. LifeVantage had a net margin of 5.25% and a trailing twelve-month return on equity of 40.72%.
View LifeVantage's earnings history

How has LifeVantage's stock price been impacted by Coronavirus?

LifeVantage's stock was trading at $11.34 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LFVN shares have decreased by 28.4% and is now trading at $8.12.
View which stocks have been most impacted by COVID-19

What guidance has LifeVantage issued on next quarter's earnings?

LifeVantage updated its FY 2021 earnings guidance on Thursday, May, 13th. The company provided earnings per share guidance of 0.900-0.930 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.930. The company issued revenue guidance of $220 million-$223 million, compared to the consensus revenue estimate of $225.99 million.

Who are LifeVantage's key executives?

LifeVantage's management team includes the following people:
  • Mr. Steven R. Fife, Pres, CEO, CFO & Director (Age 60, Pay $598.04k)
  • Mr. Kevin McMurray, Gen. Counsel (Age 59, Pay $539.95k)
  • Mr. Justin Rose, Chief Sales & Marketing Officer (Age 53, Pay $581k)
  • Mr. Matthew Cooley, Chief Operating Officer (Age 48)
  • Mr. Eric E. Marchant, VP of Compliance
  • Chris Taylor, Director of Communications
  • Ms. Michelle Oborn-Virchow, Sr. VP of HR (Age 41)
  • Ms. Calli Mott, Sr. VP of Distributor Experience
  • Mr. Dave Fleming, Sr. VP of Sales
  • Mr. Brian Dixon, Sr. VP of R&D

What is Darren Jensen's approval rating as LifeVantage's CEO?

5 employees have rated LifeVantage CEO Darren Jensen on Darren Jensen has an approval rating of 79% among LifeVantage's employees.

Who are some of LifeVantage's key competitors?

What other stocks do shareholders of LifeVantage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), (CGC), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

How do I buy shares of LifeVantage?

Shares of LFVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $8.12.

How much money does LifeVantage make?

LifeVantage has a market capitalization of $113.72 million and generates $232.91 million in revenue each year. The company earns $11.55 million in net income (profit) each year or $0.86 on an earnings per share basis.

How many employees does LifeVantage have?

LifeVantage employs 247 workers across the globe.

What is LifeVantage's official website?

The official website for LifeVantage is

Where are LifeVantage's headquarters?

LifeVantage is headquartered at 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The company can be reached via phone at 801-432-9000 or via email at [email protected]

This page was last updated on 7/30/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.